- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... documentation.Require minimal direction to complete tasks, knows how to get resources and information from established internal contacts; consult with supervisor for… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... requirements.Require minimal direction to complete tasks, know how to get resources and information from established internal contacts, and consult with supervisor… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... insurance. We also provide commuter benefits, family planning and care resources , well-being initiatives, and peer-to-peer recognition programs - demonstrating our… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... insurance. We also provide commuter benefits, family planning and care resources , well-being initiatives, and peer-to-peer recognition programs - demonstrating our… more
- Legend Biotech USA, Inc. (Atlanta, GA)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... and congress/meeting attendance.Assistance in the development of field-based MSL resources and training materials and other projects as needed.Maintain focus… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... insurance. We also provide commuter benefits, family planning and care resources , well-being initiatives, and peer-to-peer recognition programs - demonstrating our… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... insurance. We also provide commuter benefits, family planning and care resources , well-being initiatives, and peer-to-peer recognition programs - demonstrating our… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... insurance. We also provide commuter benefits, family planning and care resources , well-being initiatives, and peer-to-peer recognition programs - demonstrating our… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... insurance. We also provide commuter benefits, family planning and care resources , well-being initiatives, and peer-to-peer recognition programs - demonstrating our… more
- Legend Biotech USA, Inc. (Raritan, NJ)
- …autologous and allogenic chimeric antigen receptor T-cell, T-cell receptor (TCR-T), and natural killer (NK) cell-based immunotherapy. From our three R&D sites around ... insurance. We also provide commuter benefits, family planning and care resources , well-being initiatives, and peer-to-peer recognition programs - demonstrating our… more
